PHARMA COMPANIES SOUR ON SWISS DRUG APPLICATIONS AMID TRUMP’S MFN POLICY - SEEKINGALPHA

Trump’s MFN policy triggers pharma backlash against Swiss drug applications, geopolitical impact.